384 related articles for article (PubMed ID: 32326818)
1. Priorities for Patient-Centered Research in Valvular Heart Disease: A Report From the National Heart, Lung, and Blood Institute Working Group.
Lindman BR; Arnold SV; Bagur R; Clarke L; Coylewright M; Evans F; Hung J; Lauck SB; Peschin S; Sachdev V; Tate LM; Wasfy JH; Otto CM
J Am Heart Assoc; 2020 May; 9(9):e015975. PubMed ID: 32326818
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
[TBL] [Abstract][Full Text] [Related]
4. Transseptal transcatheter mitral valve-in-valve: A step by step guide from preprocedural planning to postprocedural care.
Guerrero M; Salinger M; Pursnani A; Pearson P; Lampert M; Levisay J; Russell H; Feldman T
Catheter Cardiovasc Interv; 2018 Sep; 92(3):E185-E196. PubMed ID: 28557344
[TBL] [Abstract][Full Text] [Related]
5. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
Coffey S; Cox B; Williams MJ
Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
[TBL] [Abstract][Full Text] [Related]
6. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter heart valve interventions: where are we? Where are we going?
Prendergast BD; Baumgartner H; Delgado V; Gérard O; Haude M; Himmelmann A; Iung B; Leafstedt M; Lennartz J; Maisano F; Marinelli EA; Modine T; Mueller M; Redwood SR; Rörick O; Sahyoun C; Saillant E; Søndergaard L; Thoenes M; Thomitzek K; Tschernich M; Vahanian A; Wendler O; Zemke EJ; Bax JJ
Eur Heart J; 2019 Feb; 40(5):422-440. PubMed ID: 30608523
[TBL] [Abstract][Full Text] [Related]
8. Non-cardiac surgery in patients with valvular heart disease.
Sorrentino R; Santoro C; Bardi L; Rigolin V; Gentile F
Heart; 2022 Jul; 108(15):1171-1178. PubMed ID: 34815334
[TBL] [Abstract][Full Text] [Related]
9. Valvular heart disease and postoperative considerations.
Miller S; Flynn BC
Semin Cardiothorac Vasc Anesth; 2015 Jun; 19(2):130-42. PubMed ID: 25975596
[TBL] [Abstract][Full Text] [Related]
10. Valvular Heart Disease in Patients ≥80 Years of Age.
Kodali SK; Velagapudi P; Hahn RT; Abbott D; Leon MB
J Am Coll Cardiol; 2018 May; 71(18):2058-2072. PubMed ID: 29724358
[TBL] [Abstract][Full Text] [Related]
11. The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions).
Grube E; Sinning JM; Vahanian A
Eur Heart J; 2014 Feb; 35(8):490-5. PubMed ID: 24385378
[TBL] [Abstract][Full Text] [Related]
12. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
[TBL] [Abstract][Full Text] [Related]
13. In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results of a 10-year surgical experience.
Pechlivanidis K; Onorati F; Petrilli G; Santini F; Milano A; Torre S; Calzaferri D; Mazzucco A; Faggian G
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):500-8.e1. PubMed ID: 24183337
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
[TBL] [Abstract][Full Text] [Related]
15. What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement?
Tourmousoglou C; Rao V; Lalos S; Dougenis D
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):837-43. PubMed ID: 25754372
[TBL] [Abstract][Full Text] [Related]
16. [Management of valvular heart disease : ESC/EACTS guidelines 2017].
Haude M
Herz; 2017 Dec; 42(8):715-720. PubMed ID: 29188357
[TBL] [Abstract][Full Text] [Related]
17. Lifetime Risks of Valvular Heart Disease and Pacemaker Use in Patients With Ankylosing Spondylitis.
Ward MM
J Am Heart Assoc; 2018 Oct; 7(20):e010016. PubMed ID: 30371264
[TBL] [Abstract][Full Text] [Related]
18. Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019.
Izumi C; Matsuyama R; Asaoka M; Iwasaki K; Takeshima T; Murphy S; Teng L; Igarashi A
J Cardiol; 2023 Jul; 82(1):29-34. PubMed ID: 36963659
[TBL] [Abstract][Full Text] [Related]
19. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.
Rosenhek R; Iung B; Tornos P; Antunes MJ; Prendergast BD; Otto CM; Kappetein AP; Stepinska J; Kaden JJ; Naber CK; Acartürk E; Gohlke-Bärwolf C
Eur Heart J; 2012 Apr; 33(7):822-8, 828a, 828b. PubMed ID: 21406443
[TBL] [Abstract][Full Text] [Related]
20. Valve disease and non-cardiac surgery.
Chambers JB
Heart; 2018 Nov; 104(22):1878-1887. PubMed ID: 29853487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
